We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,949

Outside of FDA
  • Drinker Biddle & Reath LLP
  • European Union, Global, United Kingdom, USA
  • June 30 2008

The European Directorate for the Quality of Medicines & HealthCare (EDQM, Council of Europe), recently met with the Ministry of Health of India and the Indian Pharmacopoeia Commission (IPC) to discuss improving the quality and safety of medicines in both locations, and developing joint inspections of DBR Reg Sci May - June 2008 Page 7 manufacturing sites


Canada: transparency of dealings between pharmaceutical companies and healthcare professionals
  • Norton Rose Fulbright LLP
  • Canada, European Union, France, USA
  • October 30 2013

Several countries have recently introduced legislation andor industry codes promoting the transparency of payments by pharmaceutical manufacturers


Sidley Austin LLP global pricing newsletter - volume three 2014
  • Sidley Austin LLP
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare


Pharmaceutical trade marks case law round up for 2012early 2013
  • Corrs Chambers Westgarth
  • Australia, European Union, USA
  • June 6 2013

A brief wrap-up of recent decisions relating to trade marks in the pharma space from the EU, the United States and Australia


Life sciences: 2013 legal developments you need to know about
  • Mayer Brown LLP
  • China, European Union, France, USA
  • July 16 2013

This is a short guide outlining some of the key legal developments in the life sciences sector in 2013. The developments include the Supreme Court


E.U. way ahead of the game on telehealth
  • Epstein Becker Green
  • European Union, USA
  • March 21 2013

Telehealth is expanding rapidly outside of the U.S. in both developed and developing countries. Not surprisingly, the expanded use of telehealth


Global Privacy & Cybersecurity Update Vol. 11 - September 2016
  • Jones Day
  • Australia, European Union, France, USA
  • September 12 2016

Multinational companies have faced new developments over the past year in the area of EU data protection law, from the invalidation of the U.S.-EU


Recent developments in biosimilars: Canada, EU, France and the U.S.
  • Norton Rose Fulbright Canada LLP
  • Canada, European Union, France, USA
  • January 29 2014

There have been a number of developments in biosimilars of late, including regulatory approvals in Canada issued on January 15, 2014 for two


A clinical trial data sharing commitment between the EU and the US
  • Baker & McKenzie
  • European Union, USA
  • August 19 2013

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the US Pharmaceutical Research and Manufacturers of America (PhRMA


When food production leads to prosecution
  • Davis Wright Tremaine LLP
  • European Union, USA
  • March 6 2013

Over the last few weeks, two big stories have made headlines in the food industry. Beginning in early February, news media across Europe began